Alfasigma

Alfasigma USA is the American arm of the Italian pharmaceutical company Alfasigma, specializing in the niche market of prescription medical foods. Its core business revolves around branded products like Deplin, Metanx, and Cerefolin, which are formulated to manage nutritional deficiencies associated with neurological and metabolic disorders. The company operates within a specialized regulatory framework for medical foods, targeting clear patient needs in psychiatry, diabetes care, and cognitive health. It also has connections to a broader CDMO (Contract Development and Manufacturing Organization) business through its parent company's Morpho division.

Expertise in formulation and regulatory strategy for prescription medical foods designed to address specific nutritional deficiencies linked to disease pathology (e.g., neurotransmitter imbalances, endothelial dysfunction). Supported by parent company's integrated CDMO (Morpho) for development and manufacturing.

Competes with other specialty medical food companies (e.g., Pamlab products now under Nestlé Health Science), pharmaceutical companies with adjunctive therapies, and manufacturers of high-potency dietary supplements. Differentiation is based on clinical data, brand recognition among specialists, and the specific formulation science behind its prescription-only products.